COVINNOVATIONS Trademark

Serial Number: 90525950

COVINNOVATIONS is a trademark filed by Schaefflertanz Corporation on February 11, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Schaefflertanz Corporation (5 trademarks)

3012 S Durango Dr
Las Vegas, NV 89117

Entity Type: 03

Legal Representation

Attorney of Record

Philip A Kantor

673 trademarks filed View all →

Trademark Details

Filing Date

February 11, 2021

Registration Date

Not Registered

Goods & Services

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing body fluids for microorganisms relating to infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing of body fluids relating to infectious disease, including COVID-19; Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids relating to infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious disease, including COVID-19

Medical diagnostic testing, monitoring and reporting services relating to infectious disease, including COVID-19; Medical services, namely, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses, including COVID-19, and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; Medical testing for diagnostic or treatment purposes relating to infectious disease, including COVID-19; Medical testing for diagnostic or treatment purposes in the field of infectious disease, including COVID-19

Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing of infectious disease, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing for viruses, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing of nucleic acids for infectious disease, including COVID-19

Research and development and consultation related thereto in the field of infectious disease, including COVID-19 testing; Research and development in the field of infectious disease, including COVID-19 testing; Research and development in the pharmaceutical and biotechnology fields, relating to infectious disease, including COVID-19; Research and development of technology in the field of infectious disease, including COVID-19 testing; Research and development services in the field of antibodies relating to infectious disease, including COVID-19; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines relating to infectious disease, including COVID-19; Scientific research and development relating to infectious disease, including COVID-19; Pharmaceutical research and development relating to infectious disease, including COVID-19